Trial Profile
A phase I study of a prostaglandin D2 receptor antagonist for asthma/allergic disorders
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 19 Jan 2012
Price :
$35
*
At a glance
- Drugs Prostaglandin D2 receptor antagonists (Primary)
- Indications Allergic asthma; Allergic rhinitis; Asthma
- Focus Adverse reactions
- 19 Jan 2012 New trial record